JP2003509468A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003509468A5 JP2003509468A5 JP2001524620A JP2001524620A JP2003509468A5 JP 2003509468 A5 JP2003509468 A5 JP 2003509468A5 JP 2001524620 A JP2001524620 A JP 2001524620A JP 2001524620 A JP2001524620 A JP 2001524620A JP 2003509468 A5 JP2003509468 A5 JP 2003509468A5
- Authority
- JP
- Japan
- Prior art keywords
- antagonist molecule
- monoclonal antibody
- molecule
- composition according
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40552299A | 1999-09-23 | 1999-09-23 | |
| US09/405,522 | 1999-09-23 | ||
| PCT/US2000/026095 WO2001021196A1 (en) | 1999-09-23 | 2000-09-22 | Method and compositions for inhibiting adhesion formation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003509468A JP2003509468A (ja) | 2003-03-11 |
| JP2003509468A5 true JP2003509468A5 (https=) | 2007-11-08 |
Family
ID=23604048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001524620A Pending JP2003509468A (ja) | 1999-09-23 | 2000-09-22 | 癒着形成を阻害する方法および組成物 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1223962A4 (https=) |
| JP (1) | JP2003509468A (https=) |
| KR (1) | KR20020048941A (https=) |
| CN (1) | CN1399554A (https=) |
| AU (1) | AU781442B2 (https=) |
| BR (1) | BR0014222A (https=) |
| CA (1) | CA2384812A1 (https=) |
| MX (1) | MXPA02003079A (https=) |
| WO (1) | WO2001021196A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2025685T3 (da) | 2007-08-15 | 2013-09-02 | Canadian Blood Services | Monoklonale antistoffer mod BETA3-integriner. |
| EP3485921B1 (en) | 2016-07-13 | 2025-07-23 | Mochida Pharmaceutical Co., Ltd. | Adhesion-preventing composition |
| WO2019138583A1 (ja) * | 2018-01-15 | 2019-07-18 | 持田製薬株式会社 | 癒着防止用組成物 |
| KR102318958B1 (ko) * | 2019-08-08 | 2021-10-27 | 고려대학교 산학협력단 | 인테그린 α2β1 억제제를 유효성분으로 포함하는 조직 유착 예방 또는 치료용 약제학적 조성물 |
| EP4126957A4 (en) * | 2020-03-31 | 2024-07-24 | The Regents of the University of California | COMPOSITIONS AND METHODS FOR TREATING DYSREGULATED WOUND HEALING |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE901736L (en) * | 1989-05-17 | 1990-11-17 | Fuller H B Licensing Financ | Polypeptide-antibody conjugate for inhibiting cell adhesion |
| US5753230A (en) * | 1994-03-18 | 1998-05-19 | The Scripps Research Institute | Methods and compositions useful for inhibition of angiogenesis |
| WO1999009982A1 (en) * | 1997-08-25 | 1999-03-04 | Harold Brem | Prevention of adhesions and excessive scar formation using angiogenesis inhibitors |
-
2000
- 2000-09-22 BR BR0014222-0A patent/BR0014222A/pt not_active IP Right Cessation
- 2000-09-22 WO PCT/US2000/026095 patent/WO2001021196A1/en not_active Ceased
- 2000-09-22 MX MXPA02003079A patent/MXPA02003079A/es unknown
- 2000-09-22 EP EP00970476A patent/EP1223962A4/en not_active Withdrawn
- 2000-09-22 JP JP2001524620A patent/JP2003509468A/ja active Pending
- 2000-09-22 AU AU79850/00A patent/AU781442B2/en not_active Ceased
- 2000-09-22 CN CN00816148A patent/CN1399554A/zh active Pending
- 2000-09-22 CA CA002384812A patent/CA2384812A1/en not_active Abandoned
- 2000-09-22 KR KR1020027003796A patent/KR20020048941A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6021959B2 (ja) | 炎症性腸疾患を治療するための抗体α４β７インテグリンおよびその使用 | |
| AU2016308337B2 (en) | Carrier-binding agent compositions and methods of making and using the same | |
| US12065493B2 (en) | Anti-MICA/B antibodies that block MICA/B shedding and methods of use | |
| Ioannides et al. | Pemphigus | |
| EP3348576A1 (en) | Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2) | |
| CA2155303A1 (en) | Treatment for insulin dependent diabetes | |
| RU2018100129A (ru) | Способы лечения подагры | |
| RU2013125306A (ru) | Связывающие протеины, специфичные по отношению к инсулин-подобным факторам роста, и их использование | |
| RU2010116184A (ru) | Новые антитела | |
| RU2006140407A (ru) | Антитела к гликопротеину vi и способы продуцирования и использования этих антител | |
| JP2005505256A5 (https=) | ||
| EP0995445B1 (en) | Use of IGF-1 alone or combined with growth hormone for stimulating growth | |
| JP7289913B2 (ja) | Ｔｆｐｉアンタゴニストのための投薬レジメン | |
| JP2003521916A5 (https=) | ||
| Rice et al. | Cyclic immune thrombocytopenia responsive to thrombopoietic growth factor therapy | |
| WO2019214707A1 (zh) | 包含抗pcsk9抗体的制剂及其用途 | |
| JP2002532079A5 (https=) | ||
| EP2984108B1 (en) | Anti-s100a7 antibodies for the treatment and diagnosis of cancer | |
| JP2003509468A5 (https=) | ||
| KR20250107839A (ko) | 심혈관계 질환의 치료 방법 | |
| MX2014006265A (es) | Administacion del anticuerpo alfa4beta7 hetero-dimero-especifico. | |
| KR101759687B1 (ko) | 순환하는 생물활성 가용성 tnf의 선택적 감소를 위한 조성물 및 tnf-매개 질환의 치료 방법 | |
| Mendrick et al. | II. Epitope specific induction of proteinuria by monoclonal antibodies | |
| JP2005536220A5 (https=) | ||
| Clofent‐Sanchez et al. | A case of profound and prolonged tirofiban‐induced thrombocytopenia and its correction by intravenous immunoglobulin G |